(Q30414710)

15 November 2017

Glycogen synthase kinase-3β inhibition in the medial prefrontal cortex mediates paradoxical amphetamine action in a mouse model of ADHD. (English)

1 reference

15 November 2017

Nils Christian Gassen

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25852508%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

Theo Rein

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25852508%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

3

Andreas Zellner

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25852508%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

5

Rainer Landgraf

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25852508%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

6

Carsten T Wotjak

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25852508%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

7

Elmira Anderzhanova

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25852508%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

author name string

Yi-Chun Yen

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25852508%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

language of work or name

1 reference

20 March 2015

1 reference

Frontiers in Behavioral Neuroscience

15 November 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25852508%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25852508%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

page(s)

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25852508%20AND%20SRC:MED&resulttype=core&format=json

Differential influence of dopamine transport rate on the potencies of cocaine, amphetamine, and methylphenidate

8 June 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Co-segregation of hyperactivity, active coping styles, and cognitive dysfunction in mice selectively bred for low levels of anxiety

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Transgenic mouse models for ADHD.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

GSK-3 inhibition potentiates the synaptogenic and antidepressant-like effects of subthreshold doses of ketamine

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Strain differences in profiles of dopaminergic neurotransmission in the prefrontal cortex of the BALB/C vs. C57Bl/6 mice: consequences of stress and afobazole

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Clozapine-induced locomotor suppression is mediated by 5-HT2A receptors in the forebrain

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

AKT/GSK3 signaling pathway and schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Brain region differences in regulation of Akt and GSK3 by chronic stimulant administration in mice

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

GSK-3: Functional Insights from Cell Biology and Animal Models

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Proteomic and metabolomic profiling of a trait anxiety mouse model implicate affected pathways

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Antidepressant drugs diversely affect autophagy pathways in astrocytes and neurons--dissociation from cholesterol homeostasis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Inhibition of glycogen synthase kinase-3 is necessary for the rapid antidepressant effect of ketamine in mice

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Tolerability and effects of OROS® MPH (Concerta ®) on functioning, severity of disease and quality of life in children and adolescents with ADHD: results from a prospective, non-interventional trial

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

How addictive drugs disrupt presynaptic dopamine neurotransmission

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Group II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortex

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Catecholamine influences on prefrontal cortical function: relevance to treatment of attention deficit/hyperactivity disorder and related disorders

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Overview of animal models of attention deficit hyperactivity disorder (ADHD).

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Glutamatergic model psychoses: prediction error, learning, and inference

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Molecular genetics of attention deficit hyperactivity disorder

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Inhibition of glycogen synthase kinase 3beta (GSK3beta) decreases inflammatory responses in brain endothelial cells

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Towards conceptualizing a neural systems-based anatomy of attention-deficit/hyperactivity disorder

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Akt/GSK3 signaling in the action of psychotropic drugs

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

LTP inhibits LTD in the hippocampus via regulation of GSK3beta

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Strain differences in lithium attenuation of d-amphetamine-induced hyperlocomotion: a mouse model for the genetics of clinical response to lithium

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

A novel mass spectrometry-based assay for GSK-3beta activity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Identification of glyoxalase-I as a protein marker in a mouse model of extremes in trait anxiety.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Glycogen synthase kinase 3beta (GSK3beta) mediates 6-hydroxydopamine-induced neuronal death

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Convergent evidence for impaired AKT1-GSK3beta signaling in schizophrenia

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Diverse psychotomimetics act through a common signaling pathway

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Hypodopaminergic and hypernoradrenergic activity in prefrontal cortex slices of an animal model for attention-deficit hyperactivity disorder--the spontaneously hypertensive rat.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Haloperidol-induced catalepsy is absent in dopamine D(2), but maintained in dopamine D(3) receptor knock-out mice

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Functional hyperdopaminergia in dopamine transporter knock-out mice

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Association and linkage of the dopamine transporter gene and attention-deficit hyperactivity disorder in children: heterogeneity owing to diagnostic subtype and severity

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Differences between electrically-, ritalin- and D-amphetamine-stimulated release of [3H]dopamine from brain slices suggest impaired vesicular storage of dopamine in an animal model of Attention-Deficit Hyperactivity Disorder

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Attention-deficit/hyperactivity disorder, self-regulation, and time: toward a more comprehensive theory

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Measurement of hippocampal levels of cellular second messengers following in situ freezing

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

The role of frontal lobe dysfunction in childhood hyperkinesis

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Individual and morphological differences in the behavioural response to apomorphine in rats.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4367184

Effects of sydnocarb and D-amphetamine on the extracellular levels of amino acids in the rat caudate-putamen

20 June 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2015.00067

Amphetamine increases the extracellular concentration of glutamate in striatum of the awake rat: involvement of high affinity transporter mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2015.00067

The neural correlates of attention deficit hyperactivity disorder: an ALE meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2015.00067

Alterations in regional brain metabolism in genetic and pharmacological models of reduced NMDA receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2015.00067

Proteomics and metabolomics analysis of a trait anxiety mouse model reveals divergent mitochondrial pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2015.00067

CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2015.00067

Diabetes insipidus and, partially, low anxiety-related behaviour are linked to a SNP-associated vasopressin deficit in LAB mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2015.00067

Regulation of mouse brain glycogen synthase kinase-3 by atypical antipsychotics.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2015.00067

Psychiatric Comorbidity at the Time of Diagnosis in Adults With ADHD: The CAT Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2015.00067

A double-blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2015.00067

Expression of cocaine sensitization: regulation by the medial prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2015.00067

Ineffectiveness of imipramine in children who fail to respond to methylphenidate.

21 January 2018

1 reference

https://api.crossref.org/works/10.3389%2FFNBEH.2015.00067

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25852508

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three times-daily methylphenidate in children with attention-deficit/hyperactivity disorder

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25852508

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Anti-hyperactivity medication: methylphenidate and amphetamine

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25852508

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.3389/FNBEH.2015.00067

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25852508%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25852508%20AND%20SRC:MED&resulttype=core&format=json

8 June 2020

PubMed publication ID

25852508

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25852508%20AND%20SRC:MED&resulttype=core&format=json